The Study of Unasyn-S 12g/Day for Community Acquired Pneumonia (CAP)

Status Completed

Clinical Trial Summary

Unasyn-S 12g/day (3 g four times a day) is the commonly used dosage depending on the severity for US, EU, China, Taiwan and Korea for over 20 years, however, Unasyn-S 12g/day has not yet been approved in Japan. The purpose of this trial is to evaluate the clinical efficacy and safety in Japanese adult subjects with community acquired pneumonia receiving ampicillin sodium/sulbactam sodium, 12g/day (3 g four times a day ) IV.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01189487
Study type	Interventional
Source	Pfizer
Contact
Status	Completed
Phase	Phase 3
Start date	October 2010
Completion date	April 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03303976` - Phase I to Test a New Pneumococcal Vaccine	Phase 1
Completed	`NCT02459158` - A Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial Pneumonia	Phase 1
Recruiting	`NCT06113432` - CPAP Therapy Through a Helmet or a Full Face Mask in Patients With Acute Hypoxemic Respiratory Failure: Cross-over Study	N/A
Active, not recruiting	`NCT03577964` - Development of Pneumonia Due to Alveolar Glucose Levels in Systemic Hyperglycemia
Completed	`NCT04540081` - Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer	N/A
Completed	`NCT00538694` - Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia	Phase 3
Withdrawn	`NCT02218359` - Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative and / or Gram-positive Bacterial Colonization	Phase 2
Completed	`NCT00515034` - A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia	Phase 2
Withdrawn	`NCT00245453` - Outpatient Registry Trial of Respiratory Tract Infections in Adults	Phase 4
Completed	`NCT03239665` - Vaccination Education Through Pharmacists and Senior Centers (VEPSC)	N/A
Completed	`NCT03034642` - Modulation of Steroid Immunosuppression by Alveolar Efferocytosis	N/A
Completed	`NCT04047719` - Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens
Completed	`NCT02292498` - Thermal Imaging to Diagnose and Monitor Suspected Bacterial Infections	N/A
Completed	`NCT01763008` - A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections	Phase 4
Recruiting	`NCT05976581` - Using Probability of Community-Acquired Pneumonia to Tailor Antimicrobials Among Inpatients	N/A
Completed	`NCT03551210` - Efficacy and Safety of Nemonoxacin vs Levofloxacin in Adult Patients With Community-Acquired Pneumonia	Phase 3
Completed	`NCT04158804` - PROcalcitonin Impact on Antibiotic Reduction, adverSe Events and AVoidable healthcarE Costs (ProSAVE): A RCT	N/A
Completed	`NCT00805168` - Inhaled Amikacin Solution (BAY 41-6551) as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia	Phase 3
Completed	`NCT02778672` - Thermal Imaging of the Lung on a Smartphone to Differentiate Bacterial From Non Bacterial Causes of Pneumonia	N/A
Completed	`NCT00724828` - Study Evaluating Streptococcus Pneumoniae Serotype Carriage Rate for Nasopharyngeal Carriage in Filipino Children	N/A